Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in BSX — Boston Scientific Corp

CIK 1603466 STAMFORD, CT
Back to BSX Full portfolio

Position in BSX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$231,379,016
-$756,566 QoQ
Shares Held
3,687,315
+51.5% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Mar 31, 2026
CallValue
$132,458,975
CallShares
2,110,900
PutValue
$2,020,550
PutShares
32,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $700,270,107 across 37 Medical Devices names. BSX ranks #1 (33.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
This page 		3,687,315 $231,379,016
2 EW
Edwards Lifesciences Corp
 1,826,537 $146,269,082
3 IRTC
iRhythm Holdings, Inc.
 599,405 $70,741,778
4 BRKR
Bruker Corp
 952,873 $34,417,772
5 PRCT
PROCEPT BioRobotics Corp
 1,128,543 $28,224,860
6 ATEC
Alphatec Holdings, Inc.
 2,493,575 $27,130,096
7 BBNX
Beta Bionics, Inc.
 2,525,040 $25,300,900
8 DXCM
Dexcom Inc
 257,298 $16,158,314

All Filings in BSX

Export CSV
48 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,020,550 32,200
2026-03-31 $132,458,975 2,110,900
2026-03-31 $231,379,016 3,687,315
2025-12-31 $26,564,510 278,600
2025-12-31 $232,135,582 2,434,563
2025-12-31 $15,151,115 158,900
2025-09-30 $92,299,402 945,400
2025-09-30 $159,239,704 1,631,053
2025-06-30 $332,971 3,100
2025-06-30 $1,202,992 11,200
2025-06-30 $264,299,812 2,460,663
2025-03-31 $131,144 1,300
2025-03-31 $189,708,370 1,880,535
2025-03-31 $20,690,488 205,100
2024-12-31 $200,594,766 2,245,799
2024-12-31 $2,045,428 22,900
2024-12-31 $705,628 7,900
2024-09-30 $7,382,780 88,100
2024-09-30 $4,885,540 58,300
2024-09-30 $283,396,432 3,381,819
2024-06-30 $1,517,097 19,700
2024-06-30 $240,657,944 3,125,022
2024-06-30 $2,056,167 26,700
2024-03-31 $862,974 12,600
2024-03-31 $6,081,912 88,800
2024-03-31 $162,060,284 2,366,189
2023-12-31 $272,333,949 4,710,845
2023-12-31 $12,654,609 218,900
2023-09-30 $11,557,920 218,900
2023-09-30 $339,068,611 6,421,754
2023-06-30 $188,811,908 3,490,699
2023-06-30 $1,065,573 19,700
2023-06-30 $1,227,843 22,700
2023-03-31 $89,138,451 1,781,700
2022-12-31 $9,155,398 197,869
2022-12-31 $744,947 16,100
2022-12-31 $916,146 19,800
2022-09-30 $766,854 19,800
2022-09-30 $623,553 16,100
2022-09-30 $113,315,188 2,925,773
2022-06-30 $797,578 21,400
2022-06-30 $102,229,522 2,742,944
2022-06-30 $600,047 16,100
2022-03-31 $120,504,232 2,720,800
2021-12-31 $80,838,505 1,902,978
2021-09-30 $47,103,229 1,085,578
2020-12-31 $3,415,250 95,000
2020-09-30 $1,828,730 47,860

Report a Problem

Category
Description
Email (optional, for follow-up)